Directed share issue in Senzime AB (SE) — SEK 100 million

Carnegie acted as sole global co-ordinator in the directed share issue of 5,263,158 new shares at a subscription price of SEK 19 per share. Senzime develops and markets systems, driven by unique algorithms and sensors, to follow patients ‘ nervous systems and electrical impulses – before, during and after surgery. The company’s solution is called TetraGraph, a medical technology system that digitally and continuously measures the degree of neuromuscular blockade in the patient.
June 2022.